Introduced
September 14, 2026
Mr. Bilirakis (for himself, Ms. Barragán, Mrs. Cammack, Mr. Auchincloss, Mr. Kean, and Mr. Mullin) introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Priority for Pediatric Cures Act”.